Cervical cancer: First 3-D image of an HPV oncoprotein

February 15, 2013, CNRS

(Medical Xpress)—For the first time, researchers from the Laboratoire biotechnologie et signalisation cellulaire at the Strasbourg-based Ecole supérieure de biotechnologie (CNRS/Université de Strasbourg) and Institut de génétique et de biologie moléculaire et cellulaire (CNRS/Université de Strasbourg/Inserm) have solved the three-dimensional structure of an important oncoprotein involved in cell proliferation and in the development of the human papilloma virus (HPV). Type 16 (HPV 16), which causes cervical cancer, is the most dangerous of human papilloma viruses. This work, published in Science on 8 February 2013, should make it possible to identify and improve medication to block the protein and prevent it from causing tumors.

is one of the most common cancers in the world, ranking second in terms of mortality among women. It is caused by so-called "high-risk" human papilloma viruses (HPV), of which type 16 (HPV 16) is the most dangerous. After infecting a healthy cell, HPV must stimulate it to multiply in order to reproduce itself. The E6 and E7 cause and the development of cervical cancer, which is why they are known as "oncoproteins".

For the first time, researcher Gilles Travé and his team at the laboratoire Biotechnologie et signalisation cellulaire (CNRS/University of Strasbourg) working in collaboration with researchers led by Jean Cavarelli and Bruno Keiffer of the Institut de génétique et de biologie moléculaire et cellulaire (CNRS/University of Strasbourg/) have solved the three-dimensional structures of E6 proteins in type-16 and its type 1 bovine equivalent (BPV 1). The same researchers had already solved the structure of E6 in HPV 16 in 2012, but this time the E6 proteins have been "caught" in the process of capturing target . The complete structure of an E6 protein—which is very tricky to produce in the laboratory—had remained unsolved for almost 30 years.

Success depended on two factors: the development of methods for isolating protein E6 as well as the use of nuclear magnetic resonance (NMR) and crystallography techniques. Having dealt with various aggregation and purification problems, the researchers succeeded in obtaining protein E6. The challenge then was to keep it in its folded form (so as to preserve its ability to organize itself and thus be biologically active). NMR and crystallography data made it possible to determine the structure of the E6 protein and obtain a high-resolution 3D "photograph".The three-dimensional structure of the E6 protein capturing its target reveals the exact molecular mechanism of its carcinogenic activity. It also explains the protein's remarkable ability to act as a viral terrorist and hijack many of the functions of the infected cell. This breakthrough is crucial for cervical cancer treatment, as it should make it possible to identify and improve medication to prevent the from causing tumors.

Explore further: Cervical cancer and pre-cancer cervical growths require single HPV protein

More information: Zanier, K. et al. Structural basis for hijacking of cellular LxxLL motifs by papillomavirus E6 oncoproteins. Science, 8 February 2013, Vol. 339 no. 6120 pp. 694-698, DOI: 10.1126/science.1229934.

Related Stories

Cervical cancer and pre-cancer cervical growths require single HPV protein

September 17, 2012
(Medical Xpress)—Human papillomavirus (HPV) has long been implicated in cervical cancer, but details of how it happens have remained a mystery. Now researchers at the University of Wisconsin-Madison have found that a single ...

Rating HPV biomarkers in head, neck cancers: Combinations work better than viral DNA in tumors alone

September 18, 2012
Not all head and neck cancers are created equal. Those started by infection with the human papillomavirus are less often fatal than those with other causes, such as smoking. Detection of a reliable fingerprint for HPV could ...

Scientists find cancer-causing virus in the brain, potential connection to epilepsy

January 24, 2013
Researchers at Shriner's Hospital Pediatric Research Center at the Temple University School of Medicine, and the University of Pennsylvania have evidence linking the human papillomavirus 16 (HPV16) – the most common cause ...

Recommended for you

Researchers develop a remote-controlled cancer immunotherapy system

January 15, 2018
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.

Pancreatic tumors may require a one-two-three punch

January 15, 2018
One of the many difficult things about pancreatic cancer is that tumors are resistant to most treatments because of their unique density and cell composition. However, in a new Wilmot Cancer Institute study, scientists discovered ...

New immunotherapy approach boosts body's ability to destroy cancer cells

January 12, 2018
Few cancer treatments are generating more excitement these days than immunotherapy—drugs based on the principle that the immune system can be harnessed to detect and kill cancer cells, much in the same way that it goes ...

Cancer's gene-determined 'immune landscape' dictates progression of prostate tumors

January 12, 2018
The field of immunotherapy - the harnessing of patients' own immune systems to fend off cancer - is revolutionizing cancer treatment today. However, clinical trials often show marked improvements in only small subsets of ...

FDA approves first drug for tumors tied to breast cancer genes

January 12, 2018
(HealthDay)—The U.S. Food and Drug Administration on Friday approved the first drug aimed at treating metastatic breast cancers linked to the BRCA gene mutation.

Breast cancer gene does not boost risk of death: study

January 12, 2018
Young women with the BRCA gene mutation that prompted actress Angelina Jolie's pre-emptive and much-publicised double mastectomy are not more likely to die after a breast cancer diagnosis, scientists said Friday.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.